Congress hall
08:30–09:45 am
Improving stroke outcome
Selected from submitted abstracts
Improving stroke outcome | Selected from submitted abstracts
08:30–08:45 am | Intestinal epithelial stem cell tranplants improve acute and chronic stroke impairments
Farida Sohrabji (Bryan, USA)
08:45–09:00 am | Torpor is cerebroprotective after stroke
Eric Landsness (Saint Louis, USA)
09:00–09:15 am | Discovering new blood biomarkers of neuroplasticity associated to rehabilitation outcome after stroke
Anna Rosell (Barcelona, Spain)
09:15–09:30 am | Subacute cathodal transcranial direct current stimulation rescues secondary thalamic neurodegeneration after cortical stroke in mice
Stefan Blaschke (Cologne, Germany)
09:30–09:45 am | Discussion
Conference room
08:30–09:45 am
Inflammation and the brain 2: therapeutic approaches
Selected from submitted abstracts
Inflammation and the brain 2: therapeutic approaches | Selected from submitted abstracts
08:30–08:45 am | The effect of tocilizumab in animal models of ischaemic stroke: a systematic review and meta-analysis
Torsten Rackoll (Berliln, Germany)
08:45–09:00 am | Netrin-1 alleviates blood-brain barrier dysfunction via pericyte-microglia interaction after cerebral ischemia-reperfusion injury
Qiang Li (Shanghai, China)
09:00–09:15 am | Impact of anti-platelet and anti-coagulant therapies in a microfluidic model of thromboinflammation
Astride Perrot (Paris, France)
09:15–09:30 am | St3gal5-mediated glycosylation retains CD177+ neutrophils to restrict neuroinflammation in the acute injured brain
Tingting Huang (Shanghai, China)
09:30–09:45 am | PIWIL proteins and piRNAs may play a role in reducing neuroinflammation and stabilizing genomic integrity post-stroke
Rohan Patil (Naples, Italy)
Meeting room
08:30–09:45 am
Novel concepts for optimization of therapeutic approaches
Selected from submitted abstracts
Novel concepts for optimization of therapeutic approaches | Selected from submitted abstracts
08:30–08:45 am | Vectorization of Therapeutic Agents via Click Chemistry Mediated Grafting of the Finger Domain of TPA
Camille Delahaie (Caen, France)
08:45–09:00 am | Functionalization of antioxidant cerium oxide nanoparticles with DNase I to improve ischemic stroke treatment
Norhane Salah (Paris, France)
09:00–09:15 am | Network-based drug repurposing strategy for stroke treatment: A broad therapy for a specific patient
Ana Casas (Essen, Germany)
09:15–09:30 am | Optimization of Cell Penetrating Poly-Arginine Peptides to Provide a Superior Therapeutic Index Against Severe Excitotoxic Insults In Vitro
Joe Tauskela (Ottawa, Canada)
09:30–09:45 am | Development of therapeutic and diagnostic strategies targeting the neurovascular unit following exposure to organophosphorus nerve agents
Mélanie Lagadec (Caen, France)
09:45-10:30 am | Coffee break
Congress hall
10:30 am–12:00 pm
Tissue-type Plasminogen Activator (tPA): Beyond Fibrinolysis
Tissue-type Plasminogen Activator (tPA): Beyond Fibrinolysis
10:30–11:00 am | Targeting tPA-dependent NMDA Receptor Signaling to Improve Stroke Treatment
Denis Vivien (Caen, France)
11:00–11:20 am | New advances in experimental thrombolytic formulations for the treatment of ischaemic stroke
Francisco Campos (Santiago de Compostela, Spain)
11:20–11:40 am | Leptomeningeal Collaterals Regulate rtPA-mediated Reperfusion in Ischemic Stroke
Susanne Wegener (Zurich, Switzerland)
11:40–12:00 pm | TGD001, a novel thrombolytic agent with improved efficacy in preclinical models of acute ischemic stroke and thrombotic thrombocytopenic purpura
Steven de Maat (Utrecht, Netherlands)
Conference room
10:30 am–12:00 pm
Hemorrhagic stroke II: novel models and mechanisms
Selected from submitted abstracts
Hemorrhagic stroke II: novel models and mechanisms | Selected from submitted abstracts
10:30–10:45 am | Brain endothelial cell death induced by experimental hemorrhagic stroke in vitro involves ferroptosis, necroptosis, and autophagy
Maulana Ikhsan (Lhokseumawe, Indonesia)
10:45–11:00 am | Optimising the use of Zebrafish to study Inflammasomes for Intracerebral Haemorrhage Research
Poornima Geemon (Manchester, UK)
11:00–11:15 am | Toward Novel Intracerebral Haemorrhage Stroke Models by Endovascular Approach in Swine
Teresa Gasull (Badalona, Spain)
11:15–11:30 pm | Using zebrafish larvae to study the role of cholesterol 25-hydroxylase in haematoma clearance after intracerebral haemorrhage
Abigail Bennington (Manchester, UK)
11:30–11:45 pm | Bacterial Translocation After Hemorrhagic Stroke: Effect of the hematoma size and the absence of TLR4
Jesús Pradillo (Madrid, Spain)
11:45–12:00 pm | Context-Specific Roles of CNS-Associated Macrophages in Intracerebral Hemorrhage
Mathys Bellemain-Sagnard (Caen, France)
Meeting room
10:30 am–12:00 pm
Neuroprotection and immunomodulation for stroke in post-thrombectomy era
Neuroprotection and immunomodulation for stroke in post-thrombectomy era
10:30–11:00 am | Neuroprotection and endogenous neuroregeneration after ischemia
Raphael Guzman (Basel, Switzerland)
11:00–11:20 am | Acute cerebroprotection in large animal models
Johannes Boltze (Coventry, UK)
11:20–11:40 am | Endovascular model of stroke in swine to recapitulate neurointerventions adjunct to thrombectomy
Dominika Golubczyk (Olsztyn, Poland)
11:40–12:00 pm | Biologics-based immunomodulation in patients with stroke
Dileep Yavagal (Miami, USA)
12:00-01:00 pm | Lunch break
01:00–02:30 pm | Poster viewing
Congress hall
02:30–04:00 pm
Defining a role for the immune system in stroke: preclinical and clinical evidence
Defining a role for the immune system in stroke: preclinical and clinical evidence
02:30–03:00 pm | Clinical investigation of early and long-term changes in systemic immune profiles after ischaemic stroke and their relationship to cognitive decline
Stuart Allan (Manchester, United Kingdom)
03:00–03:20 pm | Immune and non-immune effects of Interleukin-17 on stroke recovery
Mathias Gelderblom (Hamburg, Germany)
03:20–03:40 pm | Inflammation in the brain fosters plasticity and regeneration after stroke in mice
Harms Christoph (Berlin, Germany)
03:40–04:00 pm | Immunophenotyping of lymphocyte subsets in intracranial blood and cerebrospinal fluid from acute stroke patients
Ann Stowe (Lexington, USA)
Conference room
02:30–04:00 pm
Mesenchymal Stem Cell-derived Extracellular Vesicles: a Potential New Tool for Cerebral Ischemia
Mesenchymal Stem Cell-derived Extracellular Vesicles: a Potential New Tool for Cerebral Ischemia
02:30–03:00 pm | Role of polymorphonuclear neutrophils in mediating neuroprotection post-ischemia
Dirk Hermann (Essen, Germany)
03:00–03:20 pm | Mesenchymal Stem Cell-derived Extracellular Vesicles: a Potential New Tool in Regenerative Medicine
Bernd Giebel (Essen, Germany)
03:20–03:40 pm | Mesenchymal Stem Cell-derived Extracellular Vesicles: a New Therapeutic Tool for the Aged Brain after Cerebral Ischemia
Aurel Popa-Wagner (Craiova, Romania)
03:40–04:00 pm | Cell-derived extracellular vesicles as interorgan messengers under conditions of ischemic stroke
Thorsten Doeppner (Giessen, Germany)
Meeting room
02:30–04:00 pm
Early brain perturbations contribute to long–term brain aging
Early brain perturbations contribute to long–term brain aging
02:30–03:00 pm | Endocannabinoid-mediated rescue of somatosensory cortex activity, plasticity and related behaviors following an early in life concussion
Christophe Duboi (Bordeaux, France)
03:00–03:20 pm | Cerebral blood vessel adaptations to repeated hypoxia in the southern elephant seal: a new look into the neurodegenerative process
Jerome Badaut (Bordeaux, France)
03:20–03:40 pm | Assessment of Neurovascular Uncoupling: APOE Status is a Key Driver of Early Metabolic and Vascular Dysfunction
Paul R. Territo (Indianapolis, USA)
03:40–04:00 pm | Early astrocyte responses drive long term consequences after mild Traumatic Brain Injury/Concussion
Stefanie Robel (Birmingham, UK)
04:00-04:30 pm | Coffee break
Congress hall
04:30–05:30 pm
ISN&N closing session
tba
Therapeutic brain protection and repair: Feasible or ficticious?
Ulrich Dirnagl (Berlin, Germany)
Status: August 2024